Belén Viñado

ORCID: 0000-0001-6212-5886
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antibiotic Resistance in Bacteria
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Tuberculosis Research and Epidemiology
  • Antibiotics Pharmacokinetics and Efficacy
  • Mycobacterium research and diagnosis
  • Urinary Tract Infections Management
  • Bacterial Identification and Susceptibility Testing
  • Viral gastroenteritis research and epidemiology
  • Pneumonia and Respiratory Infections
  • Reproductive tract infections research
  • Antibiotic Use and Resistance
  • Respiratory viral infections research
  • Syphilis Diagnosis and Treatment
  • Streptococcal Infections and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Urinary Bladder and Prostate Research
  • Clinical Nutrition and Gastroenterology
  • Bacterial Infections and Vaccines
  • Escherichia coli research studies
  • Diagnosis and treatment of tuberculosis
  • Emergency and Acute Care Studies
  • Pediatric Urology and Nephrology Studies
  • Enterobacteriaceae and Cronobacter Research
  • Pneumocystis jirovecii pneumonia detection and treatment

Vall d'Hebron Hospital Universitari
2020-2025

Instituto de Salud Carlos III
2019-2024

Centro de Investigación Biomédica en Red
2024

Vall d'Hebron Institut de Recerca
2017-2024

Universitat Autònoma de Barcelona
1998-2023

Universitat de Barcelona
2022

Universitat Internacional de Catalunya
2022

Red Espanola de Investigacion en Patologia Infecciosa
2019-2022

Agència de Salut Pública de Catalunya
2022

Hospital Sant Joan de Déu Barcelona
2022

Experiments were performed to test whether conjugated bile acid administration would decrease bacterial overgrowth, translocation, and endotoxemia in ascitic cirrhotic rats. Cholylsarcosine, a deconjugation–dehydroxylation resistant cholylglycine, susceptible used. Rats with CCl 4 –induced cirrhosis ascites fed cholylsarcosine, cholylglycine (both at 70 mg/kg/d), or placebo for 2 weeks. Healthy rats, as controls, treated similarly. In rats receiving placebo, secretion from an acute biliary...

10.1053/jhep.2003.50116 article EN Hepatology 2003-03-01

Deranged intestinal motility, which occurs in cirrhosis, may facilitate the development of bacterial overgrowth (IBO), can lead to translocation (BT). To assess effect cisapride on IBO and BT cirrhotic rats received or a placebo for 7 days, measurements jejunal content studies were performed. In addition, fluid from 46 patients was obtained quantitative culture. Those whom gram-negative detected randomized receive not (20 mg twice per day) 1 week. Cisapride significantly reduced rats. no...

10.1053/he.2000.5746 article EN Hepatology 2000-04-01

This is a retrospective single-center study of 24 patients who received ceftazidime-avibactam plus aztreonam (CZA/ATM) for the treatment VIM-type-producing Gram-negative bacillus (GNB) infections. The bacteria isolated were Enterobacterales in 22 and Pseudomonas aeruginosa 2. Sixteen out 19 isolates showed synergistic activity. Two presented clinical failure at day 14, 30-day mortality was 17% (4/24).

10.1128/aac.00751-22 article EN Antimicrobial Agents and Chemotherapy 2022-09-14

Invasive meningococcal disease (IMD) is associated with significant global morbidity and mortality addressed by conjugated polysaccharide subcapsular vaccines. In Spain, data on 4CMenB vaccine strain coverage antimicrobial susceptibility are limited. This study aimed to describe the genomic epidemiology, predict coverage, assess of 323 Neisseria meningitidis isolates causing IMD, collected from 57 Clinical Microbiology Laboratories in Spain over 12 years (2011/12-2022/23). Whole genome...

10.1080/22221751.2025.2482696 article EN cc-by Emerging Microbes & Infections 2025-03-19

Abstract Background Several countries have recently reported the detection of ESBL-producing Shigella sonnei associated with transmission among MSM. In a previous study by our group, 2.8% spp. obtained from MSM in Barcelona between 2015 and 2019 were ESBL producers. Objectives To describe characterize emerging sexual detected 2020 to 2021 Barcelona, elucidating their connectivity contemporaneous other countries. Results From 2021, we identified that MSM, 68% S. XDR harbouring blaCTX-M-27 14%...

10.1093/jac/dkad031 article EN cc-by-nc Journal of Antimicrobial Chemotherapy 2023-02-10

Bacterial translocation (BT) can be involved in the pathogenesis of severe infections due to bacteria enteric origin that complicates bleeding cirrhotic patients. To assess effect hemorrhagic shock (HS) on incidence BT and if selective intestinal decontamination (SID) reduces this incidence, we studied six groups Sprague-Dawley rats: ascitic rats, rats exposed HS with without previous norfloxacin prophylaxis, healthy shocked prophylaxis. tended higher than (69% vs. 41%, P = .15) was...

10.1002/hep.510230419 article EN Hepatology 1996-04-01

The aim of the current study was to compare community-acquired acute pyelonephritis (CA-APN) with health care-associated (HCA-APN), describe outcomes, and identify variables that could predict antimicrobial susceptibility. We conducted an observational included all consecutive episodes (APN) in adults during 2014 at a Spanish university hospital. From each episode, demographic data, comorbidities, clinical presentation, microbiological therapy, outcome were recorded. A multivariable logistic...

10.1128/aac.01317-17 article EN Antimicrobial Agents and Chemotherapy 2017-10-03

Gonococcal infection is one of the most reported sexually transmitted infections and antimicrobial resistance in Neisseria gonorrhoeae (NG) challenging for treatment this infection. This observational study aimed to describe NG epidemiological data from patients with gonococcal eight regions Spain, updating local therapeutic guidelines.MICs penicillin, cefixime, ceftriaxone, azithromycin, ciprofloxacin, fosfomycin gentamicin were determined by Etest all isolates recovered 1 April 2018 30...

10.1093/jac/dkab037 article EN Journal of Antimicrobial Chemotherapy 2021-01-27

Abstract Objectives Our aim was to describe the frequency and severity of infectious complications after chimeric antigen receptor (CAR) T‐cell therapy in patients with large B‐cell lymphoma (LBCL). Methods We retrospectively reviewed clinical records LBCL treated CD19‐targeted CAR from July/2018 December/2021 at our institution, identified all episodes infusion until disease progression, death or last follow‐up. Results Overall, 137 were included. Thirty six percent had received ≥3 previous...

10.1111/ejh.14207 article EN European Journal Of Haematology 2024-04-26
Elena Salamanca-Rivera Zaira R. Palacios‐Baena J. Cañada Zaira Moure María Pérez‐Vázquez and 94 more Jorge Calvo Luis Martínez‐Martínez Rafael Cantón Guillermo Ruiz‐Carrascoso Cristina Pitart Ferrán Navarro Germán Bou Xavier Mulet Juan José González‐López Fran Sivianes Mercedes Delgado-Valverde Álvaro Pascual Jesús Oteo Jesús Rodríguez‐Baño Mariela Martínez Ramírez M. Lafont Emilia Cercenado Cristobal del Rosario J.L. Pérez-Arellano María Lecuona Luis López-Urrutia Lorente José Leiva José Luís del Pozo Salvador Giner Juan Frasquet Lidia Garcia Agudo Soledad Illescas Pedro de la Iglesia Rosario Sánchez Benito Eugenio Garduño Ma Isabel Fernández Natal Marta Arias Mar Olga Pérez Moreno Ana Isabel López‐Calleja José Manuel Azcona Alba Bellés Bellés Mercé García-Gónzalez Miriam Valverde Troya Begoña Palop Fernando García Garrote Jose Luis Barrios Andrés Leire López-Soria Adelina Gimeno Ester Clapés Sanchez Jennifer Villa Nuria Iglesias Nuñez Rafael Sánchez Arroyo Susana Hernando Eva Riquelme Bravo Caridad Sainz de Baranda Oscar Esparcia Rodríguez Jorge Gaitán María José Huertas María José Rodríguez Escudero Carmen Aldea N. Fernández Sánchez Antonio Casabella Ma Dolores Quesada Carmina Martí Sala Laura Mora Encarnación Clavijo Natalia Chueca Federico Juan Manuel GarcíaSánchez Fátima Galán‐Sánchez Carmen Liébana Carolina Roldán M.I. Pérez Cabeza Ma Teresa Cabezas Fernández Lucía Martínez Lamas Sonia Rey Cao Ma Isabel Paz Vidal Raquel Elisa Rodríguez Tarazona y N Andrés Amparo Coira Ma Luisa Pérez del Molino Bernal María Gomáriz Díaz Matxalen Vidal‐García Jose Luis de Tuesta Díaz M. Bravo Almudena Tinajas Fe Tubau Quintano Borja Suberviola Cañas y Maria Elie García Irene Gracia-Ahufinger Mónica González Bardanca Belén Viñado Xavier Nuvials Ignasi Roca Patricia Ruíz-Garbajosa Desirèe Gijón Vicente Pintado Alba Rivera David Gutiérrez Campos Aurora Alemán Ignacio Ayestarán Andrés Canut Blasco y Jorge Arribas García

Abstract Background Community-acquired (CA) and healthcare-associated (HCA) infections caused by carbapenemase-producing Enterobacterales (CPE) are not well characterized. The objective was to provide detailed information about the clinical molecular epidemiological features of nosocomial, HCA CA Klebsiella pneumoniae (CP-Kp) Escherichia coli (CP-Ec). Methods A prospective cohort study performed in 59 Spanish hospitals from February March 2019, including first 10 consecutive patients whom...

10.1007/s15010-024-02267-0 article EN cc-by Infection 2024-05-04

VIM-type-producing Gram-negative bacteria (GNB) infections are difficult to treat. This is a retrospective single-center study of 34 patients who received cefiderocol for the treatment GNB infections, including 25

10.3390/antibiotics13090874 article EN cc-by Antibiotics 2024-09-12
Álvaro Irigoyen Azahara Ocaña Rosa Sánchez-Mayoral Emilia Cercenado Javier Fernández and 92 more Ana López Sánchez Cruz Villuendas Antonina Arias Juan Manuel García-Lechuz María Isabel Cameo Carlos González P. Merino Iciar Rodríguez-Avial Esther Viedma Gregoria Megías Ma Pilar Ortega Cristina Pitart Cristina Colmenarejo Marina Fernández Marta Alonso A. Torralba Felipe Pérez Pablo Camacho Carmen Guerrero Caridad Sáinz de Baranda Berta Fidalgo Ángeles Sampere Noelia Hernando Fátima Galán‐Sánchez Sonia Paredes Luciana Rocha Barros Gonçalves María P. Rodríguez Carlos Fuster Xavier Mulet M. Carmen Fernández‐Santaella Germán Bou J A Antonio Guzmán Ma Dolores Quesada Jun Hao Wang David Navarro Margarita Garau Paz Díaz Maria Belen Rojas Gallegos Mariela Martínez Ángel Rodríguez Isabel Cristina Buriticá López Margarita Asensio María Eugenia Portillo Amaya C. Oteiza Antônio Pedro Genoveva Yagüe Yolanda Romero Laura Barrado Marı́a del Carmen Pérez Patricia Pérez Victoria Ortiz de la Tabla Concepción Gimeno Nuria Tormo Antonia Víñez Sánchez Patrizia Marti Ana Martín Laura Florén-Zabala Francisco Javier Chamizo-López M. B. Mora Garcia Desirée Cordero Pedro de la Iglesia Salvador Giner José Luís López-Hontangas Isabel Sánchez‐Romero José Luís González Barrios Alba Rivera Fé Tubau Nieves Gutiérrez Fernando Garcı́a-Garrote J. H. Calvo María Siller Cristina Seral Amparo Coira Eugenio Garduño Francisco J. Vasallo Emma Padilla Belén Viñado Ana Collazos Marı́a Rosa Simón Ma Auxiliadora Semiglia Teresa Alarcón María José Díez Diego Domingo Susana Sánchez Ramón Gemma Jiménez-Guerra Ma Victoria García L. Sánchez de la Puente Antônio Linkoln Alves Borges Leal Álvaro Irigoyen Azahara Ocaña Rosa Sánchez-Mayoral Emilia Cercenado

Cefiderocol is a novel siderophore-conjugated cephalosporin developed for the treatment of multidrug-resistant Gram-negative bacterial (GNB) infections. However, current gold standard cefiderocol susceptibility testing, broth microdilution (BMD) using iron-depleted cation-adjusted Mueller-Hinton broth, presents challenges many microbiology laboratories. In this study, we evaluate real-world performance disc diffusion (DD) and commercial BMD method (ComASP

10.1093/jacamr/dlae169 article EN cc-by JAC-Antimicrobial Resistance 2024-09-03

Introduction Increasing rates of antimicrobial resistance in Neisseria gonorrhoeae cause problems for treating gonorrhoea. Aim This observational study aimed to describe isolates from all patients found infected with N. , Barcelona, Spain, between 2013 and 2017, available susceptibility data. Methods Minimum inhibitory concentrations (MICs) penicillin (PEN), cefixime (CFM), ceftriaxone (CRO), azithromycin (AZM), ciprofloxacin (CIP), spectinomycin (SPT), fosfomycin (FOF) gentamicin (GEN) were...

10.2807/1560-7917.es.2020.25.42.1900576 article EN cc-by Eurosurveillance 2020-10-22

We analyzed the effect of COVID-19 on healthcare demand and invasive pneumococcal disease in children Catalonia, Spain. Compared with 2018-2019, we noted large reductions activities incidence 2020. These changes likely resulted from nonpharmaceutical measures implemented during pandemic.

10.3201/eid2811.211741 article EN cc-by Emerging infectious diseases 2022-10-26

Introduction Infections caused by carbapenem-resistant Enterobacterales (CRE) and Pseudomonas aeruginosa , including isolates producing acquired carbapenemases, constitute a prevalent health problem worldwide. The primary objective of this study was to determine the distribution different carbapenemases among carbapenemase-producing (CPE, specifically Escherichia coli Klebsiella pneumoniae Enterobacter cloacae complex, aerogenes ) P. (CPPA) in Spain from January 2014 December 2018. Methods A...

10.3389/fmicb.2023.1247804 article EN cc-by Frontiers in Microbiology 2023-09-08

The Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test (AMTDT) was adapted for the detection of tuberculosis complex in 224 nonrespiratory specimens from 188 patients. sensitivity and specificity AMTDT such specimens, after resolution discrepant results, were 85.7 100%, respectively. Pretreatment with sodium dodecyl (lauryl) sulfate is mandatory to obtain consistent reproducible results. use 500 microliters decontaminated specimen improves test. Because detects stable rRNA...

10.1128/jcm.35.1.307-310.1997 article EN Journal of Clinical Microbiology 1997-01-01

We evaluated a rapid point-of-care test for the detection of Chlamydia trachomatis in specimens from 278 sex workers attending sexually transmitted infection clinics Guatemala. The sensitivity and specificity compared to results PCR were 62.96% 99.60%, respectively. performed moderately well as screening tool context which clinical follow-up visits are infrequent.

10.1128/jcm.01975-08 article EN Journal of Clinical Microbiology 2008-12-04

The progressive increase of infections produced by extensively drug-resistant carbapenemase-producing Klebsiella pneumoniae (XDR-CPKP) represents an important threat to public health. Unfortunately, optimal therapeutic options are scarce. Retrospective studies have recommended combined therapy with more than one antibiotic and, recently, a double-carbapenem regimen has been reported be effective alternative therapy. Here, we describe episode sepsis in immunocompromised patient after...

10.1089/mdr.2017.0129 article EN Microbial Drug Resistance 2017-07-14

It is well known that one of the differences between murine and human tuberculosis lack intragranulomatous necrosis in former. The aim this study was to create a feasible reproducible model an experimental which should be present. Considering Shwartzman reaction as possible explanation for tuberculosis, C57Bl/6 mice, infected aerogenically with virulent strain Mycobacterium were intranasally inoculated lipopolysaccharide (LPS) on day 19 postinfection (p.i.). Twenty-four hours later,...

10.1046/j.1365-3083.2001.00842.x article EN Scandinavian Journal of Immunology 2001-01-01

Background: There is no experience with ciprofloxacin for the treatment of carbapenemase-producing Gram-negative bacteria (CP-GNB) infections. Methods: This a retrospective single-centre study where we describe clinical evolution all consecutive adult patients who received monotherapy CP-GNB Primary outcomes were failure (defined as death, lack improvement or switch to another drug) at day 14 and 30-day all-cause mortality. Results: Nineteen included. Fifteen (79%) men, median age was 74...

10.3390/antibiotics13121138 article EN cc-by Antibiotics 2024-11-26
Coming Soon ...